Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 664.49M P/E - EPS this Y 20.00% Ern Qtrly Grth -
Income -43.16M Forward P/E -13.05 EPS next Y -33.30% 50D Avg Chg -4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 4.54 EPS next 5Y - 52W High Chg -46.00%
Recommedations 2.00 Quick Ratio 11.79 Shares Outstanding 82.11M 52W Low Chg 10.00%
Insider Own 3.14% ROA -20.70% Shares Float 79.52M Beta 0.58
Inst Own 32.07% ROE -31.88% Shares Shorted/Prior 20M/19.89M Price 8.22
Gross Margin - Profit Margin - Avg. Volume 877,169 Target Price 34.67
Oper. Margin - Earnings Date May 7 Volume 616,765 Change 0.86%
About Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Anavex Life Sciences Corp. News
03/25/24 Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
03/18/24 Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
02/26/24 12 $10 Stocks That Will Triple
02/26/24 Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
02/08/24 Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
02/07/24 Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
02/01/24 Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
01/31/24 Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal
01/31/24 GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
01/31/24 Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to Trade
01/24/24 Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why
01/24/24 Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans
01/16/24 Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
01/09/24 Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
01/08/24 5 Small-Cap Stocks to Play the January Effect
01/08/24 Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders
01/03/24 Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
01/03/24 Anavex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
01/02/24 Anavex Life Sciences Provides an Update on Rett Syndrome Program
12/20/23 Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
AVXL Chatroom

User Image Blarcamesine Posted - 53 minutes ago

$AVXL Missling going to cash in some chips on a mega rise?? If the FDA says OK this can be at all time highs! 30s easily .. but then higher .. let the FUNds begin!!

User Image Blarcamesine Posted - 1 hour ago

$AVXL so with Missling converting options .. and new FDA Alzheimers guidelines Monday or Tuesday Anavex could announce that the FDA will accept Anavex data for submission for Full approval (probably with priority review) this may soar and Missling will dump the 73k shares he converted into the rise .. That is my assumption!

User Image Blarcamesine Posted - 1 hour ago

$AVXL both surrogate endpoints or clinical endpoints may support a traditional approval! It's like Anavex wrote this.. It is wonderful for Anavex! We could get full approval!

User Image Blarcamesine Posted - 1 hour ago

$AVXL March 2024 .. FDA draft guidance! Duration of a trial.. The FDA will accept nearly anything! They really lowered the bar..

User Image getafrickinlife Posted - 9 hours ago

$AVXL Hmmm odd day today. This "Junk proteins" and S1R graphic was posted to the Anavex Facebook page then later removed. Odd... Also, there was a filing of a Rule 144 "proposed sale of securities" relating to stock options that were exercised about 9 days before the expiration date. Of which, it should be noted that until a corresponding form 4 is filed, the actual disposition of the shares acquired from the stock option exercise is unknown. What is known is that the strike price was $1.32 for 73,380 and with the rule 144 disclosure made, the CEO can sell or propose to sell these shares should he wish. The form 4 should be filed in 2 biz days and we will know then if the CEO held or sold the acquired shares.

User Image georgejjl Posted - 9 hours ago

$AVXL Seriously...Seriously...Seriously Anyone who looks at the graph of the last 45 minutes of the trading day can see that the bashers, FUDsters and shorters painted the tape today!!!! That is a FACT. Seriously...Seriously...Seriously GOD bless,

User Image georgejjl Posted - 10 hours ago

$AVXL The bashers, FUDsters and shorters painted the the tape at the close today. GOD bless,

User Image stjernerogvann Posted - 11 hours ago

@Swinging4Thefenc3 I have been making good money on both $SAVA and $AVXL - wrt to $SAVA multiples of the current share price over the last three years. You apparently think being up $2 over several years is good - I don't.

User Image georgejjl Posted - 11 hours ago

$AVXL Tesla’s $25,000 Car Means Tossing Out the 100-Year-Old Assembly Line A new ‘unboxed’ production system could slash costs in half — if the EV maker can actually pull it off. https://www.bloomberg.com/news/articles/2024-03-28/tesla-s-tsla-new-unboxed-manufacturing-process-aims-to-cut-costs-50 Good luck and [b]GOD[/b] bless,

User Image papatrick Posted - 12 hours ago

$AVXL up to now....

User Image bartwood Posted - 13 hours ago

$AVXL

User Image papatrick Posted - 13 hours ago

$AVXL up to now, no one can proves he exercised his options

User Image Lilac Posted - 13 hours ago

$AVXL :)

User Image Look_2_Learn Posted - 13 hours ago

$AVXL FYI maybe it is a form of reverse psychology. Missling selling/exercising options trying to make people believe it will go lower. Maybe his mind game is to release some good news soon, journal, EMA, or FDA news. And 💥… SP 📈🤣🤣🤪 lol. Wouldn’t that be fun! Haha this is for entertainment purposes only. I don’t think Missling can really do reverse psychology. Cheers 🍻

User Image JV716 Posted - 13 hours ago

$AVXL he knows it’s going lower.

User Image papatrick Posted - 14 hours ago

$AVXL why are you talking about that situation today?

User Image georgejjl Posted - 14 hours ago

$AVXL Expect AVXL stock to close green near the high of the day, hod on relatively heavy buying before 4:00 PM today in anticipation of news soon. Have a blessed and happy Easter. Good luck and GOD bless,

User Image Trulieve Posted - 14 hours ago

$AVXL https://www.fda.gov/media/110903/download has anyone seen this updated guidance from the FDA? It seems that this is HUGE NEWS! See lines 145-210 but what it looks like is that you only need one endpoint met to be cleared for approval now. For us ADAS COG does it. Didn't we do great with this endpoint? I hope we are going hard for approval right now and not waiting for EMA. How come this is not out in the mainstream?

User Image Termi0208 Posted - 14 hours ago

$AVXL We do not know if he has sold because the form 4 has not yet been filed. Form 4 must be filed with the SEC within two days of the transaction.

User Image bscatter Posted - 15 hours ago

$AVXL PapaTrick says screw the tinfoil hat, I want a whole damn body suit!

User Image papatrick Posted - 15 hours ago

$AVXL when Missling exercise options, we receive alerts, news, we see it here and everywhere....where did you see, post a link please???

User Image papatrick Posted - 15 hours ago

$AVXL did he sold or not yet? yesterday?

User Image papatrick Posted - 15 hours ago

$AVXL 73000 options at 1.32 expiring May 8 and he sold them at 5? So he think we are going lower until may 8??? After he is on vacation until october at least, maybe nov... So no news next week at his presentation... Time to sell in block

User Image georgejjl Posted - 15 hours ago

$AVXL The Anavex 3-71 P2 in Schizophrenia is worth at least $14 BILLION. https://www.reuters.com/markets/deals/bristol-myers-buy-karuna-therapeutics-14-billion-wsj-2023-12-22/ https://www.anavex.com/post/anavex-life-sciences-initiates-placebo-controlled-u-s-phase-2-clinical-trial-of-anavex-3-71-in-schi Good luck and GOD bless,

User Image ForestFoxes Posted - 15 hours ago

$AVXL 🕊️ https://stocktwits.com/Termi0208/message/565395998

User Image Termi0208 Posted - 16 hours ago

$AVXL He exercised at 1.32 $. Form 10k:

User Image papatrick Posted - 16 hours ago

$AVXL can someone tell me if Missl8ng exercised options at 5$?? 2 times this morning i see posts related to that???

User Image georgejjl Posted - 16 hours ago

$AVXL European study finds popular ALS drug ineffective A chemical known as TUDCA, which many ALS patients use as a supplement, was not significantly better than a placebo at slowing the disease in a large clinical trial. https://www.biopharmadive.com/news/als-tudca-trial-europe/711510/ However, Anavex’s blarcamesine will prove to be most effective for treating ALS https://m.youtube.com/watch?v=J5jj_Pmc9q0 Good luck and GOD bless,

User Image badprecog Posted - 17 hours ago

$AVXL It was probably my post that a P2 in Schizophrenia is worth $200MM and cash on hand equaled the current MC that got this turned around! Bahahaaaa! or its Easter and AVXL is getting... oh sorry no blasphemy on stocktwitts.

User Image georgejjl Posted - 17 hours ago

$AVXL Expect ABSOLUTELY HUGE NEWS SOON regarding AVXL stock!!! Good luck and GOD bless,

Analyst Ratings
HC Wainwright & Co. Buy Jan 3, 24
HC Wainwright & Co. Buy Nov 28, 23
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Jul 20, 23
HC Wainwright & Co. Buy Jun 29, 23
HC Wainwright & Co. Buy May 2, 23
HC Wainwright & Co. Buy Mar 31, 23
BTIG Buy Feb 9, 23
HC Wainwright & Co. Buy Feb 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MISSLING CHRISTOPHER U President and CEO President and CEO Jun 28 Sell 7.98 268,000 2,138,640 1,018,210 06/30/23
MISSLING CHRISTOPHER U President and CEO President and CEO Jun 28 Option 1.6 500,000 800,000 1,250,210 06/30/23
Skarpelos Athanasios Director Director May 25 Option 0.92 50,000 46,000 1,356,458 05/27/22
Skarpelos Athanasios Director Director May 25 Sell 9.06 50,000 453,000 1,306,458 05/27/22
MISSLING CHRISTOPHER U President and CEO President and CEO Jul 01 Option 1.32 51,620 68,138 1,069,830 07/01/21
MISSLING CHRISTOPHER U President and CEO President and CEO Jul 01 Sell 26 51,620 1,342,120 1,018,210 07/01/21
Boenisch Sandra PFO and Treasurer PFO and Treasurer Jul 01 Option 4.96 166,696 826,812 189,659 07/01/21
Boenisch Sandra PFO and Treasurer PFO and Treasurer Jul 01 Sell 26.53 166,696 4,422,445 22,963 07/01/21
FAVUS ELLIOT Director Director May 25 Option 4.12 145,000 597,400 145,000 05/25/21
FAVUS ELLIOT Director Director May 25 Sell 11.7 145,000 1,696,500 05/25/21
FAVUS ELLIOT Director Director Feb 26 Option 2.93 145,500 426,315 145,000 02/26/21
FAVUS ELLIOT Director Director Feb 26 Sell 12.66 145,500 1,842,030 02/26/21
Donhauser Peter D.O. Director Director Feb 23 Buy 12.8 1,165 14,912 1,165 02/23/21